Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation…

By L. Wallentin, B. Lagerqvist, S. Husted, F. Kontny, E. Ståhle, E. Swahn. The Lancet, 2000

626 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/4c76f1f78eabf128abdfb7ea8c0586c4b3250a9d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Robert M. Califf
2. D. A. Morrow
3. Joseph S. Alpert
4. Judith Hochman
5. B. Maron
6. N. Rifai
7. Douglas P. Zipes
8. P. Ridker

In Surgery

1. Robert M. Califf
2. Joseph S. Alpert
3. Judith Hochman
4. N. Rifai
5. Peter Libby
6. P. Ridker

Citations in the corpus

• Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. (2001, background): “1 ng/mL.(17) While other clinical indicators, such as ST-segment depression, also appear to be useful for stratifying patients with respect to the benefit of an invasive management strategy,(8) cardiac troponins appear to confer additional information.”
• Task Force on Sudden Cardiac Death of the European Society of Cardiology. (2001, background): “In one study, there was a significant reduction in mortality in the invasive group at 1 year([163]), but SCD was not specifically reported.”
• ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients (2002, background): “Thus, both the FRISC II (28,29) and TACTICS-TIMI 18 (7,30) trials, the 2 most recent trials comparing invasive vs.”
• Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. (2005, neutral): “(%) 486 (33) 47 (23) 356 (41) 1114 (46) 688 (31) 60 (46) 660 (37) 3411/9208 (37.”